Pulpitis - Irreversible Clinical Trial
Official title:
Evaluation of Chitosan Scaffold and Mineral Trioxide Aggregate Pulpotomy in Mature Permanent Molars With Irreversible Pulpitis
Verified date | May 2022 |
Source | University of Alexandria |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of this study is to evaluate the clinical and radiographic outcomes of Chitosan scaffold and Mineral trioxide aggregate (MTA) when used as pulpotomy agents in mature permanent teeth with irreversible pulpitis.
Status | Completed |
Enrollment | 30 |
Est. completion date | December 20, 2020 |
Est. primary completion date | October 30, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 20 Years to 50 Years |
Eligibility | Inclusion Criteria: - Participants free from any systemic disease. - Deep caries in a permanent lower molar with mature roots. - Probing pocket depth and mobility within normal limits. - No signs of pulpal necrosis including sinus tract or swelling. - Vital bleeding pulp tissue should be present in all canals after complete pulpotomy. - The tooth is restorable. - Clinical diagnosis of symptomatic irreversible pulpitis based on subjective and objective examinations: - Subjective examination: Patients complaining of intermittent or spontaneous pain or pain exacerbated by dramatic temperature changes especially to cold stimuli and lasting for a few seconds to several hours. - Objective examination: - Clinical examination: Teeth that will experience immediate, excruciatingly painful sensation as soon as the cold stimulus is placed on and which may last for a while even after the removal of the stimulus. - Radiographic examination: Preoperative radiographs will be taken using a paralleling device. - The periapical index developed by Orstavik et al. (1986)(35) will be used to score cases with periapical rarefaction during diagnosis and follow-up periods. It consists of five categories: 1. Normal periapical structures. 2. Small changes in bone structures. 3. Change in bone structure with mineral loss. 4. Periodontitis with well-defined radiolucent area. 5. Severe periodontitis with exacerbating features. Score 1 and 2 are considered healthy, score 3-5 are considered diseased - The teeth that will be included should have score 1 or 2. Exclusion Criteria: - Negative response to cold testing. - No pulp exposure after caries excavation. - Bleeding could not be controlled in 10 minutes after 2.5% NaOCl - Absence of bleeding from any of the canals. - Teeth with radiographic signs of internal resorption. - Pulpal calcifications. - Participants with stainless-steel wires and brackets. |
Country | Name | City | State |
---|---|---|---|
Egypt | Faculty of Dentistry, Alexandria University | Alexandria |
Lead Sponsor | Collaborator |
---|---|
Nourhan M.Aly | Alexandria University |
Egypt,
Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, Dohan AJ, Mouhyi J, Dohan DM. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Mar;101(3):e56-60. — View Citation
Ho MH, Kuo PY, Hsieh HJ, Hsien TY, Hou LT, Lai JY, Wang DM. Preparation of porous scaffolds by using freeze-extraction and freeze-gelation methods. Biomaterials. 2004 Jan;25(1):129-38. — View Citation
Kumar V, Juneja R, Duhan J, Sangwan P, Tewari S. Comparative evaluation of platelet-rich fibrin, mineral trioxide aggregate, and calcium hydroxide as pulpotomy agents in permanent molars with irreversible pulpitis: A randomized controlled trial. Contemp Clin Dent. 2016 Oct-Dec;7(4):512-518. — View Citation
Li F, Liu X, Zhao S, Wu H, Xu HH. Porous chitosan bilayer membrane containing TGF-ß1 loaded microspheres for pulp capping and reparative dentin formation in a dog model. Dent Mater. 2014 Feb;30(2):172-81. doi: 10.1016/j.dental.2013.11.005. Epub 2013 Dec 12. — View Citation
Parirokh M, Torabinejad M. Mineral trioxide aggregate: a comprehensive literature review--Part III: Clinical applications, drawbacks, and mechanism of action. J Endod. 2010 Mar;36(3):400-13. doi: 10.1016/j.joen.2009.09.009. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain Assessment | Postoperative pain will be recorded on Numerical Rating Pain Scale (NRS) that will be given to the patient to record his pain intensity in the range between 0-10, until the seventh day after treatment. Pain on the NRS will be further categorized as: No pain (0), Mild (1-3), Moderate (4-6), and Severe (7-10) pain. | one week | |
Primary | Mineralization Activity | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization | baseline | |
Primary | Mineralization Activity | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization | 1 month | |
Primary | Mineralization Activity | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization | 3 months | |
Primary | Mineralization Activity | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization | 6 months | |
Primary | Mineralization Activity | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization | 9 months | |
Primary | Mineralization Activity | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the rate of tooth mineralization | 12 months | |
Primary | Root Canal Obliteration | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration | baseline | |
Primary | Root Canal Obliteration | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration | 1 month | |
Primary | Root Canal Obliteration | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration | 3 months | |
Primary | Root Canal Obliteration | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration | 6 months | |
Primary | Root Canal Obliteration | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration | 9 months | |
Primary | Root Canal Obliteration | Post-operative digital radio-graphic follow up will be done using the paralleling device to assess the presence/absence of canal obliteration | 12 months | |
Primary | Internal Root Resorption | Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption | baseline | |
Primary | Internal Root Resorption | Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption | 1 month | |
Primary | Internal Root Resorption | Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption | 3 months | |
Primary | Internal Root Resorption | Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption | 6 months | |
Primary | Internal Root Resorption | Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption | 9 months | |
Primary | Internal Root Resorption | Post-operative digital radiographic follow up will be done using the paralleling device in order to assess the presence/absence of internal resorption | 12 months | |
Secondary | Changes in the dental pulp in treated teeth | This will be performed in comparison to a non-affected tooth with clinical vitality and without any additional past treatment. All observers will analyze the images using the following rating scale regarding to alterations of signal intensity of the dental pulp at nT1w, fsT1w, and fsT2w at distinct time intervals (1 = no signs of alterations of signal intensity of the dental pulp between affected and non-affected teeth, 2 = slightly alterations of signal intensity of the dental pulp between affected and nonaffected teeth, and 3 = obvious alterations of signal intensity of the dental pulp between affected and nonaffected teeth) | 6 months | |
Secondary | Peri-radicular/furcal pathosis | Cone beam computed tomography (CBCT) analysis will be performed to detect presence/absence of any peri-radicular/furcal pathosis | 12 months | |
Secondary | Internal and external root resorption | Cone beam computed tomography (CBCT) analysis will be performed to detect presence/absence of internal or external root resorption | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT06268912 -
Cryoanalgesia for Irreversible Pulpitis
|
N/A | |
Completed |
NCT06330519 -
Impact of Different Techniques on The Efficacy of Anaesthesia in Mandibular Molars With Acute Irreversible Pulpitis
|
Phase 4 | |
Recruiting |
NCT05336682 -
Evaluation of Lesion Sterilization and Tissue Repair Techniques Versus Pulpectomy in Primary Molars With Inflammed Pulp
|
N/A | |
Recruiting |
NCT06438523 -
A-prf,Nanochitosan Combined With A-prf Compared to Chitosan for Symptomatic Irreversible Pulpitis of Mature Teeth
|
N/A | |
Recruiting |
NCT03956199 -
Pulpotomy vs.Root Canal Treatment in Managing Irreversible Pulpitis
|
N/A | |
Completed |
NCT03174860 -
Effect of Preoperative Diclofenac Potassium on Articaine Buccal Infitration Success
|
Phase 2/Phase 3 | |
Completed |
NCT05853185 -
Assessing Success of MTA and Pre-mixed Bioceramic in Mature Teeth With Irreversible Pulpitis With Full Pulpotomy.
|
Phase 4 | |
Not yet recruiting |
NCT03612323 -
Comparison Between Intraligamentary Piroxicam and Articaine
|
Early Phase 1 | |
Not yet recruiting |
NCT02953912 -
Assessment of Postoperative Pain Using Reciproc Versus One Shape Files in Patients With Irreversible Pulpitis
|
N/A | |
Completed |
NCT04719247 -
Clinical and Radiographic Evaluation of Turmeric, Thymus Vulgaris, Nigella Sativa and Aloe Vera as Pulpotomy Medicaments in Primary Teeth
|
N/A | |
Completed |
NCT05582317 -
Efficacy of Combination of Biodentine and Simvastatin as a Pulp Capping Materials in Vital Pulpotomy of Primary Molars
|
N/A | |
Recruiting |
NCT05406557 -
Partial Versus Miniature Pulpotomy in Teeth With Irreversible Pulpitis
|
N/A | |
Recruiting |
NCT05402098 -
Outcome Following Endodontic Treatment Using Traditional Access Versus Conservative Access
|
N/A | |
Recruiting |
NCT05902936 -
Evaluation of Nano Bioactive Glass Combined With i-PRF Scaffold in Vital Pulp Treatments
|
N/A | |
Recruiting |
NCT03553407 -
Analgesic Effect of Low Intensity Laser in Patients With Pulpitis of Mandibular Molars.
|
N/A | |
Completed |
NCT05904184 -
Comparison of Calcium Silicate-based Sealer and Epoxy Resin-based Sealer
|
Phase 3 | |
Not yet recruiting |
NCT03916900 -
Postoperative Pain and Success Rate in Pulpotomy Versus Root Canal Treatment
|
N/A | |
Completed |
NCT06088446 -
Effect of Intrapulpal Injections on the Post-endodontic Pain
|
N/A | |
Enrolling by invitation |
NCT05964933 -
Pulpotomy vs Root Canal Treatment for Teeth With Symptomatic Irreversible Pulpitis
|
N/A | |
Withdrawn |
NCT04996641 -
Endodontic-Restorative Pre-Radiation Therapy of Head and Neck Cancer Patients
|
N/A |